CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (NASDAQ:CERS) announced today that it has entered into an agreement with Haemonetics Corporation (NYSE:HAE) for the sale of Haemonetics’ Acrodose ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback